These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 30723129)
1. A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection. Bazzone LE; King M; MacKay CR; Kyawe PP; Meraner P; Lindstrom D; Rojas-Quintero J; Owen CA; Wang JP; Brass AL; Kurt-Jones EA; Finberg RW mBio; 2019 Feb; 10(1):. PubMed ID: 30723129 [TBL] [Abstract][Full Text] [Related]
2. Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus. Baggen J; Thibaut HJ; Hurdiss DL; Wahedi M; Marceau CD; van Vliet ALW; Carette JE; van Kuppeveld FJM mBio; 2019 Aug; 10(4):. PubMed ID: 31409686 [TBL] [Abstract][Full Text] [Related]
3. ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection. Bazzone LE; Zhu J; King M; Liu G; Guo Z; MacKay CR; Kyawe PP; Qaisar N; Rojas-Quintero J; Owen CA; Brass AL; McDougall W; Baer CE; Cashman T; Trivedi CM; Gack MU; Finberg RW; Kurt-Jones EA Nat Commun; 2024 May; 15(1):4153. PubMed ID: 38755212 [TBL] [Abstract][Full Text] [Related]
5. NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. Schwarz EM; Badorff C; Hiura TS; Wessely R; Badorff A; Verma IM; Knowlton KU J Virol; 1998 Jul; 72(7):5654-60. PubMed ID: 9621024 [TBL] [Abstract][Full Text] [Related]
6. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo. Ilyinskii PO; Wang R; Balk SP; Exley MA J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320 [TBL] [Abstract][Full Text] [Related]
7. Role of invariant NKT cells in lipopolysaccharide-induced lethal shock during encephalomyocarditis virus infection. Ando T; Ito H; Ohtaki H; Kanbe A; Hirata A; Hara A; Seishima M Immunobiology; 2017 Feb; 222(2):350-357. PubMed ID: 27665995 [TBL] [Abstract][Full Text] [Related]
8. Exploitation of nuclear protein SFPQ by the encephalomyocarditis virus to facilitate its replication. Zhou B; Wu F; Han J; Qi F; Ni T; Qian F Biochem Biophys Res Commun; 2019 Feb; 510(1):65-71. PubMed ID: 30661786 [TBL] [Abstract][Full Text] [Related]
9. Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Exley MA; Bigley NJ; Cheng O; Shaulov A; Tahir SM; Carter QL; Garcia J; Wang C; Patten K; Stills HF; Alt FW; Snapper SB; Balk SP Immunology; 2003 Dec; 110(4):519-26. PubMed ID: 14632651 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the Host Lipid Landscape to Promote RNA Virus Replication: The Picornavirus Encephalomyocarditis Virus Converges on the Pathway Used by Hepatitis C Virus. Dorobantu CM; Albulescu L; Harak C; Feng Q; van Kampen M; Strating JR; Gorbalenya AE; Lohmann V; van der Schaar HM; van Kuppeveld FJ PLoS Pathog; 2015 Sep; 11(9):e1005185. PubMed ID: 26406250 [TBL] [Abstract][Full Text] [Related]
11. Cocaine enhances myocarditis induced by encephalomyocarditis virus in murine model. Wang JF; Zhang J; Min JY; Sullivan MF; Crumpacker CS; Abelmann WH; Morgan JP Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H956-63. PubMed ID: 11834492 [TBL] [Abstract][Full Text] [Related]
12. Mutations in Encephalomyocarditis Virus 3A Protein Uncouple the Dependency of Genome Replication on Host Factors Phosphatidylinositol 4-Kinase IIIα and Oxysterol-Binding Protein. Dorobantu CM; Albulescu L; Lyoo H; van Kampen M; De Francesco R; Lohmann V; Harak C; van der Schaar HM; Strating JR; Gorbalenya AE; van Kuppeveld FJ mSphere; 2016; 1(3):. PubMed ID: 27303747 [TBL] [Abstract][Full Text] [Related]
13. The Origin, Dynamic Morphology, and PI4P-Independent Formation of Encephalomyocarditis Virus Replication Organelles. Melia CE; van der Schaar HM; de Jong AWM; Lyoo HR; Snijder EJ; Koster AJ; van Kuppeveld FJM; Bárcena M mBio; 2018 Apr; 9(2):. PubMed ID: 29666283 [TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of adenovirus-mediated small interfering RNAs against encephalomyocarditis virus challenge in mice. Bai J; Jiang K; Zhang L; Wang X; Wang X; Li Y; Jiang P J Virol Methods; 2012 Nov; 185(2):204-12. PubMed ID: 22790206 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of encephalomyocarditis virus replication by shRNA targeting 1D and 3AB genes in vitro and in vivo. Bai J; Jiang K; Zeshan B; Wang X; Li Y; Jiang P Virus Genes; 2012 Apr; 44(2):183-90. PubMed ID: 22052534 [TBL] [Abstract][Full Text] [Related]
17. Embryonic stem cells attenuate viral myocarditis in murine model. Wang JF; Yang Y; Wang G; Min J; Sullivan MF; Ping P; Xiao YF; Morgan JP Cell Transplant; 2002; 11(8):753-8. PubMed ID: 12588107 [TBL] [Abstract][Full Text] [Related]
18. Encephalomyocarditis virus 2A protein is required for viral pathogenesis and inhibition of apoptosis. Carocci M; Cordonnier N; Huet H; Romey A; Relmy A; Gorna K; Blaise-Boisseau S; Zientara S; Kassimi LB J Virol; 2011 Oct; 85(20):10741-54. PubMed ID: 21849462 [TBL] [Abstract][Full Text] [Related]
19. Kishimoto M; Hang'ombe BM; Hall WW; Orba Y; Sawa H; Sasaki M J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33533710 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of encephalomyocarditis experimental infection in young piglets: a potential animal model to study viral myocarditis. Gelmetti D; Meroni A; Brocchi E; Koenen F; Cammarata G Vet Res; 2006; 37(1):15-23. PubMed ID: 16336922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]